Machine learning to predict post-therapy dosimetry for 177Lu-PSMA I&T treatment

被引：0
作者：
Shi, K. [1 ]
Xue, S. [1 ]
Gafita, A. [2 ]
Dong, C. [2 ]
Zhao, Y. [2 ]
Tetteh, G. [2 ]
Menze, B. H. [2 ]
Afshar-Oromieh, A. [1 ]
Eiber, M. [2 ]
Rominger, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-441
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
[41]   Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T [J].
Hartrampf, Philipp E. ;
Weinzierl, Franz-Xaver ;
Serfling, Sebastian E. ;
Pomper, Martin G. ;
Rowe, Steven P. ;
Higuchi, Takahiro ;
Seitz, Anna Katharina ;
Kuebler, Hubert ;
Buck, Andreas K. ;
Werner, Rudolf A. .
CANCERS, 2022, 14 (03)
[42]   Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [177Lu]Lu-PSMA-I&T 177 Lu]Lu-PSMA-I&T Therapy [J].
Resch, Sandra ;
Ziegler, Sibylle I. ;
Sheikh, Gabriel ;
Unterrainer, Lena M. ;
Zacherl, Mathias J. ;
Bartenstein, Peter ;
Boening, Guido ;
Brosch-Lenz, Julia ;
Delker, Astrid .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (08) :1272-1278
[43]   The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival [J].
Emine Acar ;
Özhan Özdoğan ;
Ayşegül Aksu ;
Erkan Derebek ;
Recep Bekiş ;
Gamze Çapa Kaya .
Annals of Nuclear Medicine, 2019, 33 :681-688
[44]   Comparison of absorbed dose to kidneys using quantitative SPECT/CT and whole body planar images for 177Lu-PSMA I&T in prostate cancer therapy [J].
Ghodoosi, E. Karimi ;
D'Alessandria, C. ;
Eiber, M. ;
Li, W. ;
Navab, N. ;
Ziegler, S. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 :S112-S113
[45]   Impact of cross-irradiation on single time-point dosimetry in 177Lu-PSMA therapy [J].
Vergnaud, L. ;
Badel, J. ;
Giraudet, A. ;
Sarrut, D. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 :S804-S804
[46]   Patient-specific pharmacokinetics and dosimetry over multiple therapy cycles during 177Lu-based radionuclide therapy: a study for 177Lu-DOTATATE and 177Lu-PSMA [J].
Gosewisch, A. ;
Ermoschkin, L. ;
Ilhan, H. ;
Todica, A. ;
Vamacka, L. ;
Bartenstein, P. ;
Boening, G. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 :S270-S271
[47]   Insights into treatment optimization: Mathematical modeling of tumor growth in 177Lu-PSMA therapy [J].
Zaid, Nouran ;
Bastiaannet, Remco ;
Hobbs, Robert ;
Sgouros, George .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65
[48]   Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T [J].
Karimzadeh, Amir ;
Soeiro, Paula ;
Feuerecker, Benedikt ;
Hecker, Charlotte-Sophie ;
Knorr, Karina ;
Heck, Matthias M. ;
Tauber, Robert ;
Alessandria, Calogero D. ' ;
Weber, Wolfgang A. ;
Eiber, Matthias ;
Rauscher, Isabel .
JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) :1765-1771
[49]   Evaluation of radiation safety in 177Lu-PSMA therapy and development of outpatient treatment protocol [J].
Demir, Mustafa ;
Abuqbeitah, Mohammad ;
Uslu-Besli, Lebriz ;
Yildirim, Ozlem ;
Yeyin, Nami ;
Cavdar, Iffet ;
Vatankulu, Betul ;
Gunduz, Huseyin ;
Kabasakal, Levent .
JOURNAL OF RADIOLOGICAL PROTECTION, 2016, 36 (02) :269-278
[50]   Value of Post-Therapy Quantitative SPECT for Monitoring Response to 177Lu-PSMA-617 Therapy [J].
Meyer, Catherine ;
Yilmaz, Burcak ;
Szidonya, Laszlo ;
Winters, Celeste ;
Mench, Anna ;
Mallak, Nadine ;
Mittra, Erik .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65
12345